Clear Cell Renal Cell Carcinoma With a Poorly-Differentiated Component: A Novel Variant Causing Potential Diagnostic Difficulty

被引：0

作者：

Taneja, Kanika ^{[1
]}

Cheng, Liang ^{[2
]}

Al-Obaidy, Khaleel ^{[2
]}

Kao, Chia-Sui ^{[3
]}

Barletta, Justine ^{[4
]}

Howitt, Brooke ^{[3
]}

Wasco, Matthew ^{[5
]}

Palanisamy, Nallasivam ^{[1
]}

Gupta, Nilesh ^{[1
]}

Rogers, Craig ^{[1
]}

Carskadon, Shannon ^{[1
]}

Chen, Ying-Bei ^{[6
]}

Antic, Tatjana ^{[7
]}

Tretiakova, Maria ^{[8
]}

Williamson, Sean ^{[1
]}

机构：

[1] Henry Ford Hlth Syst, Detroit, MI USA

[2] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[5] St Joseph Mercy Hosp, Ann Arbor, MI 48104 USA

[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[7] Univ Chicago, Chicago, IL 60637 USA

[8] Univ Washington, Seattle, WA 98195 USA

来源：

LABORATORY INVESTIGATION | 2019年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

965

引用

页数：2

共 50 条

[21] Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
Weaver, Chaston
Bin Satter, Khaled
Richardson, Katherine P.
Tran, Lynn K. H.
Tran, Paul M. H.
Purohit, Sharad
BIOMEDICINES, 2022, 10 (11)
[22] Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma
Kroeze, S. G. C.
Bijenhof, A. M.
Bosch, J. L. H. R.
Jans, J. J. M.
CANCER BIOMARKERS, 2010, 7 (06) : 261 - 268
[23] Mucin-secreting clear cell renal cell carcinoma. A rare variant of conventional renal cell carcinoma
Fernando Val-Bernal, J.
Salcedo, Waleska
Val, Daniel
Parra, Alejandro
Francisca Garijo, M.
ANNALS OF DIAGNOSTIC PATHOLOGY, 2013, 17 (02) : 226 - 229
[24] Clinical outcomes of checkpoint inhibitors in metastatic non-clear cell renal cell carcinoma and clear cell renal cell carcinoma with variant features.
Chang, Guy vin
Ellithi, Moataz
Elnair, Radowan
Bleeker, Jonathan
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[25] LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma
Li, Lei
Qin, Sen
Tan, Hongwei
Zhou, Jiexue
AGING-US, 2024, 16 (04): : 4033 - 4051
[26] ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma
Gao, Wu-niri
Chen, Li-gang
Bao, Lu-ri
He, Ning
Hu, Ta-la
Lai, Can
Xu, Rui-feng
Wang, Xi-feng
Wang, Jing-yuan
Zhao, Jian-rong
Meng, Yan
SCIENTIFIC REPORTS, 2024, 14 (01):
[27] De-clear cell differentiated renal cell carcinoma - a new therapeutic target
Lawson, Keith A.
Linehan, W. Marston
NATURE REVIEWS UROLOGY, 2025, 22 (02) : 73 - 74
[28] Diagnostic Utility Focusing on Clear and Eosinophilic Cytoplasmic Features of Clear Cell Renal Cell Carcinoma
Ohe, Chisato
Yoshida, Takashi
Amin, Mahul
Atsumi, Naho
Yasukochi, Yoshiki
Ikeda, Junichi
Higasa, Koichiro
Tsuta, Koji
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 648 - 649
[29] Diagnostic Utility Focusing on Clear and Eosinophilic Cytoplasmic Features of Clear Cell Renal Cell Carcinoma
Ohe, Chisato
Yoshida, Takashi
Amin, Mahul
Atsumi, Naho
Yasukochi, Yoshiki
Ikeda, Junichi
Higasa, Koichiro
Tsuta, Koji
MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 648 - 649
[30] Cuproptosis: A potential therapeutic target in clear cell renal cell carcinoma
Zhao, Yuetong
Li, Jie
Lu, Xiaojie
Wu, Shuang
Xing, Yunze
Fang, Yaxuan
Yang, Bo
CHINESE MEDICAL JOURNAL, 2024, 137 (11) : 1378 - 1380

← 1 2 3 4 5 →